Eye

Study: steroid shows potential for treating cataracts without surgery

By • Nov 6, 2015
Cataracts are the leading cause of blindness worldwide.
National Eye Institute, National Institutes of Health

Scientists have identified a chemical that could one day be used in eye drops to treat cataracts — potentially eliminating the need for expensive surgery, the only treatment option currently available.

The research team was led by the University of Michigan in Ann Arbor but included researchers from the University of Washington in Seattle and Washington University in St. Louis. The group found that eye drops made with a type of steroid could partially reverse cataracts in mice.

Recycling eyeglasses with a 21st century tweak

By • Jul 5, 2013

This article first appeared in the St. Louis Beacon: “There is writing on that blackboard!”

“Hey, those people on stage have features on their faces!”

“I don’t really have to read the newspaper from across the room!”

St. Louis-based Mobius wins FDA approval to start production of eye surgery drug

By • Feb 9, 2012
(via Flickr/orangeacid)

The U.S. Food and Drug Administration has given St. Louis-based Mobius Therapeutics LLC the go-ahead to start production of a drug for use in eye surgery.

Mobius plans to have other St. Louis-area companies make and distribute the new drug, called Mitosol, which is FDA-approved for use in surgeries to treat glaucoma. Glaucoma is one of the leading causes of blindness in the United States.